Evaluation of aztreonam in the treatment of severe bacterial infections (Q35646167)

9 August 2017

title

Evaluation of aztreonam in the treatment of severe bacterial infections (English)

1 reference

9 August 2017

1 reference

Romero-Vivas J

1 reference

9 August 2017

Rodríguez-Créixems M

1 reference

9 August 2017

Bouza E

1 reference

9 August 2017

Hellín T

1 reference

9 August 2017

Guerrero A

1 reference

9 August 2017

Martínez-Beltrán J

1 reference

9 August 2017

García de la Torre M

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 August 1985

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

published in

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

222-226

1 reference

Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Metabolism and pharmacokinetics of aztreonam in healthy subjects

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Effect of aztreonam on throat and stool flora of cancer patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Binding of monobactams to penicillin-binding proteins of Escherichia coli and Staphylococcus aureus: relation to antibacterial activity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Antibiotic sensitivity testing. Report of an international collaborative study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Gram-Negative Rod Bacteremia: Microbiologic, Immunologic, and Therapeutic Considerations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Results of a Clinical Trial of Cefoxitin, a New Cephamycin Antibiotic

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Controlled Comparison of Amikacin and Gentamicin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Monobactams--monocyclic beta-lactam antibiotics produced by bacteria.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Antibacterial activity of a monocyclic beta-lactam SQ 26,776.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Pharmacology of aztreonam after intravenous infusion

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Evaluation of lamoxactam in the treatment of severe bacterial infections

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Piperacillin therapy for serious bacterial infections.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180223

Urine osmolality. A definitive test of renal function

25 September 2018

1 reference

12 December 2020

1 reference

12 December 2020

Moxalactam therapy for bacterial infections

1 reference

12 December 2020

In-vivo properties of SQ 26,776

1 reference

12 December 2020

Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects

1 reference

12 December 2020

Parenteral toxicological profile of the monocyclic beta-lactam antibiotic SQ 26,776 in mice, rats and dogs

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.28.2.222

1 reference

9 August 2017

1 reference

9 August 2017

1 reference